retatrutide trial weight loss data just delivered the most powerful ever recorded in a Phase 3 obesity trial. At 104 weeks, participants on the 12 mg dose lost an average of 85 pounds What caught my attention wasn't
Pay in 4 interest-free payments of $5.67 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
What caught my attention wasn't just the number. It was what the number represents. New Phase 3 trial data for retatrutide showed an average weight loss of 28.3% at the highest dose The data coming out of early retatrutide trials is just insane. I'm so curious to see what happens once there's FDA approval. Retatrutide Achieves Up to 30.3% Average Weight Loss in Phase 3 TRIUMPH 1 Trial AJMC Retatrutide study sees significant weight loss in obesity drug study VisualAbstract: Retatrutide reduces body weight by 17.5% in patients with obesity 2 Minute Medicine Retatrutide, a new weight loss drug not available on the market yet, is showing promising results in trials. Dr. LaPook explains its doing much more than what current medications can. CBS News
Store: www.allread.ai · Domain: www.allread.ai
